今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
附件
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2038次   下载 1906 本文二维码信息
码上扫一扫!
化纤复肝方抗肝纤维化的临床研究
谢碧红, 杨觉民, 吴引伟
南京市第二医院中西医结合科, 南京, 210003
摘要:
[目的]观察中药化纤复肝方在抗肝纤维化方面的疗效。[方法]选取62例肝纤维化患者随机分为两组,治疗组32例,对照组30例,治疗6个月。观察治疗前后两组患者的症状、体征、肝功能及肝纤维化指标的变化,评价中药化纤复肝方抗肝纤维化的疗效。[结果]治疗组改善肝纤维化患者的症状、恢复肝功能、降低血清肝纤维化指标明显优于对照组(P<0.05)。[结论]化纤复肝方有比较良好的抗肝纤维化的效果。
关键词:  肝纤维化  化纤复肝方  临床研究
DOI:10.11656/j.issn.1672-1519.2009.02.09
分类号:
基金项目:江苏省科委社会发展基金资助项目(BS2005011)
Clinical research on Huaxianfugan Prescription in treating hepatic fibrosis
XIE Bi-hong, YANG Jue-min, WU Yin-wei
Nanjing Second Hospital, Nanjing 210003, China
Abstract:
[Objective] To investigate the effect of Huaxianfugan Prescription in treating hepatic fibrosis. [Methods] Sixty-two cases with hepatic fibrosis were randomly divided into treatment group (32 cases) and control group (30 cases) with a course of treatment for 6 months. The symptoms,signs,liver function and the index of hepatic fibrosis were observed before and after treatment,and the effect of Huaxianfugan prescription in treating hepatic fibrosis was evaluated. [Results] The curative effect of treatment group was superior to that of control group in improving the symptoms and liver function,and decreasing the serum index of hepatic fibrosis (P<0.05). [Conclusion] Huaxianfugan Prescription has a good effect in anti-hepatic fibrosis.
Key words:  hepatic fibrosis  Huaxianfugan Prescription  clinical research
关注公众号二维码